Drug intelligence / Profile preview

niacin

Development stage
Approved
Lead developer
Astellas Pharma
Modality
Small Molecules
Administration
Oral, Intravenous, Intramuscular
01

Overview

Niacin, also known as vitamin B3 or nicotinic acid, is a water-soluble B-complex vitamin essential for human health. It plays a critical role in energy metabolism by helping convert food into usable energy and is necessary for the proper function of the nervous system, digestive system, and skin. At higher therapeutic doses, niacin acts as an antihyperlipidemic agent: it lowers LDL cholesterol and triglycerides while raising HDL cholesterol. Niacin is FDA-approved to treat pellagra (niacin deficiency), hyperlipidemia, mixed dyslipidemia, severe hypertriglyceridemia, and to reduce the risk of nonfatal myocardial infarction in patients with a history of heart attack and high cholesterol. It may be used alone or in combination with statins or bile acid-binding resins[1][2][3][7][8].

Brand names
NiacorNiaspanEndur-acinSlo-NiacinB3-500-GrB-3-500-GrB 3-500-GrHDL BenefitB-3-50B3-50B 3-50
Other names
vitamin B3烟酸 (Chinese)nicotinic acid
02

Targets

HCAR2 (Hydroxycarboxylic acid receptor 2)

Beyond the preview

Go deeper on niacin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on niacin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call